Cryo-Cell International, Inc.
(NYSE Mkt: CCEL)
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
3.950
+0.100
(+2.60%)
Range
3.707 - 3.982
(7.42%)
Open
3.707
Previous Close
3.850
Bid Price
4.520
Bid Volume
9
Ask Price
11.840
Ask Volume
9
Volume
1,571
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis